This preliminary study opens a way to understanding the mechanisms of how BET proteins exert their role in anaplastic thyroid cancer and how their inhibition may represent a therapeutic target for the treatment of a type of tumor which is to date still hardly curable. The gene discussed is DNER; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.